サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1298836

馬ヘルスケア市場：製品別、適応症別、流通チャネル別、地域別 2023-2028年

Equine Healthcare Market by Product, Indication, Distribution Channel, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 142 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
馬ヘルスケア市場：製品別、適応症別、流通チャネル別、地域別 2023-2028年
出版日: 2023年06月14日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の馬ヘルスケア市場規模は2022年に14億3,000万米ドルに達しました。今後、IMARC Groupは、市場は2023年から2028年の間に6.60%の成長率（CAGR）を示し、2028年までに20億7,000万米ドルに達すると予測しています。馬の人口の急激な増加、馬の健康や適切な栄養摂取に関する飼い主の意識の高まり、高度な画像診断技術の活用などが市場を牽引する主な要因となっています。

馬ヘルスケアは、馬の病気の診断、治療、予防に焦点を当てた獣医学の一分野です。ワクチン、駆虫薬、局所治療薬、関節サプリメント、プレバイオティクス、ハエ取りスプレー、蹄コンディショナー、防腐剤、パフォーマンス添加剤など、さまざまな製品を利用します。馬のヘルスケアには、予防ケア、疾病管理、跛行治療、生殖ケア、口腔衛生、リハビリテーション、行動問題への対処などが含まれます。全体的な健康状態を改善し、将来の合併症を予防し、病気の早期発見を可能にし、繁殖を成功させ、寿命を延ばし、跛行、歯の問題、感染症、肥満、ヘルペス、狂犬病などの重篤な病気のリスクを軽減します。

馬ヘルスケア市場の動向：

競馬、農業、コンパニオンとして馬が広く利用されているため、馬の人口が急速に増加していることが、市場成長を促進する主な要因の1つです。予防ケア、繁殖サービス、リハビリテーションセンター、ワクチン、健康補助食品などの馬ヘルスケアサービスや製品は、最適なパフォーマンスを確保し、合併症を予防し、怪我から守り、病気のリスクを軽減するために広く利用されています。これに加えて、馬の健康と適切な栄養摂取の重要性に関する馬主の意識の高まりが、もう一つの成長促進要因として作用しています。さらに、動物福祉を支援し、責任ある飼養を促進し、質の高いヘルスケア施設へのアクセスを提供するためのさまざまな政府イニシアチブの実施は、市場成長にプラスの影響を与えています。さらに、デジタルX線撮影、超音波検査、内視鏡検査などの高度な画像診断技術の活用により、馬体の詳細な断面画像が得られるため、筋骨格系の損傷、跛行、内部疾患の診断が可能になり、市場の成長に寄与しています。このほか、バイタルサイン、活動レベル、行動を継続的にモニタリングし、あらゆる健康問題の早期発見を容易にする馬用ウェアラブル健康モニタリング装置の最近の市場開拓が、市場成長に弾みをつけています。さらに、レース、ジャンプ、馬場馬術、耐久乗馬などの馬術スポーツの増加が市場成長を後押ししています。消費者の支出能力の上昇、ペットの人間化という新たな動向、広範な研究開発（R&D）活動、eコマース産業の急速な拡大など、その他の要因も市場成長を促進すると予想されます。

本レポートで扱う主な質問

  • 世界の馬ヘルスケア市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 世界の馬ヘルスケア市場における市場促進要因、市場抑制要因、市場機会は何か？
  • それぞれの促進要因、抑制要因、機会が世界の馬ヘルスケア市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的な馬ヘルスケア市場はどの国か？
  • 製品別の市場内訳は？
  • 馬ヘルスケア市場で最も魅力的な製品は？
  • 適応症別の市場内訳は？
  • 馬ヘルスケア市場で最も魅力的な適応症は？
  • 流通チャネル別の市場内訳は？
  • 馬ヘルスケア市場で最も魅力的な流通チャネルは？
  • 世界の馬ヘルスケア市場の競合構造は？
  • 世界の馬ヘルスケア市場における主要プレーヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の馬ヘルスケア市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 医薬品
    • 市場動向
    • 主要セグメント
      • 抗炎症剤
      • 寄生虫駆除薬
      • その他
    • 市場予測
  • ワクチン
    • 市場動向
    • 主要セグメント
      • 生ワクチン
      • 組み換えワクチン
      • その他
    • 市場予測
  • 薬用飼料添加物
    • 市場動向
    • 市場予測
  • 診断薬
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：適応症別

  • 筋骨格系疾患
    • 市場動向
    • 市場予測
  • パラサイトコントロール
    • 市場動向
    • 市場予測
  • 馬ヘルペスウイルス
    • 市場動向
    • 市場予測
  • 馬脳脊髄炎
    • 市場動向
    • 市場予測
  • 馬インフルエンザ
    • 市場動向
    • 市場予測
  • 西ナイルウイルス
    • 市場動向
    • 市場予測
  • 破傷風
    • 市場動向
    • 市場予測
  • 狂犬病
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：流通チャネル別

  • 動物病院・クリニック
    • 市場動向
    • 市場予測
  • 小売薬局・ドラッグストア
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド市場
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要プレーヤー
  • 主要プレーヤーのプロファイル
    • Boehringer Ingelheim International GmbH
    • Ceva
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Esaote SpA
    • Hallmarq Veterinary Imaging
    • IDEXX Laboratories Inc.
    • Merck & Co. Inc.
    • Vetoquinol S.A.
    • Zoetis Inc

本レポートに掲載されている企業リストは一部です。

図表

List of Figures

  • Figure 1: Global: Equine Healthcare Market: Major Drivers and Challenges
  • Figure 2: Global: Equine Healthcare Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Equine Healthcare Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Equine Healthcare Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Equine Healthcare Market: Breakup by Indication (in %), 2022
  • Figure 6: Global: Equine Healthcare Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Equine Healthcare Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Equine Healthcare (Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Equine Healthcare (Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Equine Healthcare (Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Equine Healthcare (Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Equine Healthcare (Medicated Feed Additives) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Equine Healthcare (Medicated Feed Additives) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Equine Healthcare (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Equine Healthcare (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Equine Healthcare (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Equine Healthcare (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Equine Healthcare (Musculoskeletal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Equine Healthcare (Musculoskeletal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Equine Healthcare (Parasite Control) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Equine Healthcare (Parasite Control) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Equine Healthcare (Equine Herpes Virus) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Equine Healthcare (Equine Herpes Virus) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Equine Healthcare (Equine Encephalomyelitis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Equine Healthcare (Equine Encephalomyelitis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Equine Healthcare (Equine Influenza) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Equine Healthcare (Equine Influenza) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Equine Healthcare (West Nile Virus) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Equine Healthcare (West Nile Virus) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Equine Healthcare (Tetanus) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Equine Healthcare (Tetanus) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Equine Healthcare (Rabies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Equine Healthcare (Rabies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Equine Healthcare (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Equine Healthcare (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Equine Healthcare (Veterinary Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Equine Healthcare (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Equine Healthcare (Retail Pharmacies and Drug Stores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Equine Healthcare (Retail Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: North America: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: North America: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United States: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United States: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Canada: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Canada: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Asia-Pacific: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Asia-Pacific: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: China: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: China: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Japan: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Japan: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: India: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: India: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: South Korea: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: South Korea: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Australia: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Australia: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Indonesia: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Indonesia: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Europe: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Europe: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Germany: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Germany: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: France: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: France: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: United Kingdom: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: United Kingdom: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Italy: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Italy: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Spain: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Spain: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Russia: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Russia: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Latin America: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Latin America: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Brazil: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Brazil: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Mexico: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Mexico: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Others: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Others: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Middle East and Africa: Equine Healthcare Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Middle East and Africa: Equine Healthcare Market: Breakup by Country (in %), 2022
  • Figure 88: Middle East and Africa: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Global: Equine Healthcare Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Equine Healthcare Industry: Value Chain Analysis
  • Figure 91: Global: Equine Healthcare Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Equine Healthcare Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Equine Healthcare Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Equine Healthcare Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Equine Healthcare Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Equine Healthcare Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Equine Healthcare Market: Competitive Structure
  • Table 7: Global: Equine Healthcare Market: Key Players
目次
Product Code: SR112023A7779

The global equine healthcare market size reached US$ 1.43 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.07 Billion by 2028, exhibiting a growth rate (CAGR) of 6.60% during 2023-2028. The rapid increase in the equine population, rising awareness among owners regarding equine health and proper nutrition, and the utilization of advanced imaging techniques represent some of the key factors driving the market.

Equine healthcare is a branch of veterinary medicine that focuses on the diagnosis, treatment, and prevention of diseases in horses. It involves the utilization of various products, such as vaccines, dewormers, topical treatments, joint supplements, prebiotics, fly sprays, hoof conditioners, antiseptics, and performance additives. Equine healthcare includes preventive care, illness management, lameness treatment, reproductive care, oral hygiene, rehabilitation, and addressing behavioral issues. It assists in improving overall health, preventing future complications, allowing early disease detection, facilitating successful breeding, promoting a longer lifespan, and reducing the risk of serious diseases, such as lameness, dental problems, infections, obesity, herpes, and rabies.

Equine Healthcare Market Trends:

The rapid increase in the equine population due to the widespread utilization of horses in racing, farming, and as companions is one of the primary factors propelling the market growth. Equine healthcare services and products, such as preventive care, reproductive services, rehabilitation centers, vaccines, and health supplements, are widely used to ensure optimum performance, prevent complications, protect from injuries, and reduce the risk of illnesses. In addition to this, rising awareness among the owners regarding the importance of equine health and proper nutrition is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to support animal welfare, promote responsible ownership, and provide access to high-quality healthcare facilities is positively influencing the market growth. Additionally, the utilization of advanced imaging techniques, such as digital radiography, ultrasound, and endoscopy, to provide detailed cross-sectional images of the horse's body, thus allowing the diagnosis of musculoskeletal injuries, lameness, and internal diseases, is contributing to the market growth. Besides this, the recent development of wearable health monitoring devices for horses, which allows continuous monitoring of vital signs, activity levels, and behavior to facilitate early detection of any health issues, is providing an impetus to the market growth. Moreover, the growing number of equine sports, such as racing, jumping, dressage, and endurance riding, is propelling the market growth. Other factors, including rising expenditure capacities of consumers, emerging trends of pet humanization, extensive research and development (R&D) activities, and rapid expansion of the e-commerce industry, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global equine healthcare market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product, indication, and distribution channel.

Product Insights:

Drugs

Anti-Inflammatory Drugs

Parasiticide Drugs

Others

Vaccines

Live Attenuated Vaccine

Recombinant Vaccine

Others

Medicated Feed Additives

Diagnostics

Others

The report has provided a detailed breakup and analysis of the equine healthcare market based on the product. This includes drugs (anti-inflammatory drugs, parasiticide drugs, and others), vaccines (live attenuated vaccine, recombinant vaccine, and others), medicated feed additives, diagnostics, and others. According to the report, drugs represented the largest segment.

Indication Insights:

Musculoskeletal Disorders

Parasite Control

Equine Herpes Virus

Equine Encephalomyelitis

Equine Influenza

West Nile Virus

Tetanus

Rabies

Others

A detailed breakup and analysis of the equine healthcare market based on the indication has also been provided in the report. This includes musculoskeletal disorders, parasite control, equine herpes virus, equine encephalomyelitis, equine influenza, West Nile virus, tetanus, rabies, and others. According to the report, parasite control accounted for the largest market share.

Distribution Channel Insights:

Veterinary Hospitals and Clinics

Retail Pharmacies and Drug Stores

A detailed breakup and analysis of the equine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals and clinics and retail pharmacies and drug stores. According to the report, veterinary hospitals and clinics accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for equine healthcare. Some of the factors driving the North America equine healthcare market included the rising equine population, supportive government policies, and significant technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global equine healthcare market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Esaote SpA, Hallmarq Veterinary Imaging, IDEXX Laboratories Inc., Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global equine healthcare market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global equine healthcare market?
  • What is the impact of each driver, restraint, and opportunity on the global equine healthcare market?
  • What are the key regional markets?
  • Which countries represent the most attractive equine healthcare market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the equine healthcare market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the equine healthcare market?
  • What is the breakup of the market based on distribution channel?
  • Which is the most attractive distribution channel in the equine healthcare market?
  • What is the competitive structure of the global equine healthcare market?
  • Who are the key players/companies in the global equine healthcare market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Equine Healthcare Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Product

  • 6.1  Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Anti-Inflammatory Drugs
      • 6.1.2.2 Parasiticide Drugs
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2  Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Live Attenuated Vaccine
      • 6.2.2.2 Recombinant Vaccine
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3  Medicated Feed Additives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Diagnostics
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7   Market Breakup by Indication 

  • 7.1  Musculoskeletal Disorders
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Parasite Control
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Equine Herpes Virus
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Equine Encephalomyelitis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5  Equine Influenza
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6  West Nile Virus
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7  Tetanus
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8  Rabies
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9  Others
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast

8   Market Breakup by Distribution Channel

  • 8.1  Veterinary Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Retail Pharmacies and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  Drivers, Restraints, and Opportunities

  • 10.1  Overview
  • 10.2  Drivers
  • 10.3  Restraints
  • 10.4  Opportunities

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2  Ceva
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3  Dechra Pharmaceuticals PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  Elanco Animal Health Incorporated
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5  Esaote SpA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6  Hallmarq Veterinary Imaging
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7  IDEXX Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8  Merck & Co. Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9  Vetoquinol S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10  Zoetis Inc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.